Learning from failure.
The launch of a new initiative to share data from failed clinical trials of investigational drugs for Alzheimer's disease provides both a promising opportunity to improve drug development in this field, as well as a novel mechanism to learn more from negative trials in general.
D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D016206:Databases, Bibliographic; D007211:Indoles / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use*; D017211:Treatment Failure
D007211:Indoles; D018697:Nootropic Agents; C010119:latrepirdine